PHASE-II RANDOMIZED TRIAL COMPARING HIGH-DOSE CISPLATIN WITH MODERATE-DOSE CISPLATIN AND CARBOPLATIN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER

被引：56

作者：

SCULIER, JP

KLASTERSKY, J

GINER, V

BUREAU, G

THIRIAUX, J

DABOUIS, G

EFREMIDIS, A

RIES, F

BERCHIER, MC

SERGYSELS, R

MOMMEN, P

PAESMANS, M

机构：

[1] HOSP DOCTOR PESET,VALENCIA,SPAIN

[2] GRP MED ST REMI,REIMS,FRANCE

[3] CHU NANTES,NANTES,FRANCE

[4] HOSP ST SAVAS,ATHENS,GREECE

[5] CTR HOSP LUXEMBOURG,LUXEMBOURG,LUXEMBOURG

[6] HOP HAYANGE,HAYANGE,FRANCE

[7] HOP ST PIERRE & ERASME,BRUSSELS,BELGIUM

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1994年 / 12卷 / 02期

关键词：

D O I：

10.1200/JCO.1994.12.2.353

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：353 / 359

页数：7

共 36 条

[11] CISPLATIN DOSE INTENSITY IN NON-SMALL CELL LUNG-CANCER - PHASE-II RESULTS OF A DAY-1 AND DAY-8 HIGH-DOSE REGIMEN [J].

GANDARA, DR ;

WOLD, H ;

PEREZ, EA ;

DEISSEROTH, AB ;

DOROSHOW, J ;

MEYERS, F ;

MCWHIRTER, K ;

HANNIGAN, J ;

DEGREGORIO, MW .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (10) :790-794

[12] PHASE-II STUDY OF CARBOPLATIN IN UNTREATED, INOPERABLE NON-SMALL-CELL LUNG-CANCER [J].

GATZEMEIER, U ;

HECKMAYR, M ;

HOSSFELD, DK ;

ZSCHABER, R ;

ACHTERRATH, W ;

LENAZ, L .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (05) :369-372

[13] DETERMINATION OF NUMBER OF PATIENTS REQUIRED IN A PRELIMINARY AND A FOLLOW-UP TRIAL OF A NEW CHEMOTHERAPEUTIC AGENT [J].

GEHAN, EA .

JOURNAL OF CHRONIC DISEASES, 1961, 13 (04) :346-&

[14] WR-2721 AND HIGH-DOSE CISPLATIN - AN ACTIVE COMBINATION IN THE TREATMENT OF METASTATIC MELANOMA [J].

GLOVER, D ;

GLICK, JH ;

WEILER, C ;

FOX, K ;

GUERRY, D .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) :574-578

[15] CISPLATIN AND VINDESINE COMBINATION CHEMOTHERAPY FOR ADVANCED-CARCINOMA OF THE LUNG - A RANDOMIZED TRIAL INVESTIGATING 2 DOSAGE SCHEDULES [J].

GRALLA, RJ ;

CASPER, ES ;

KELSEN, DP ;

BRAUN, DW ;

DUKEMAN, ME ;

MARTINI, N ;

YOUNG, CW ;

GOLBEY, RB .

ANNALS OF INTERNAL MEDICINE, 1981, 95 (04) :414-420

[16] CISPLATIN NEUROTOXICITY - THE RELATIONSHIP BETWEEN DOSAGE, TIME, AND PLATINUM CONCENTRATION IN NEUROLOGIC TISSUES, AND MORPHOLOGICAL EVIDENCE OF TOXICITY [J].

GREGG, RW ;

MOLEPO, JM ;

MONPETIT, VJA ;

MIKAEL, NZ ;

REDMOND, D ;

GADIA, M ;

STEWART, DJ .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (05) :795-803

[17] CISPLATIN AND CARBOPLATIN IN COMBINATION FOR THE TREATMENT OF STAGE-IV OVARIAN-CARCINOMA [J].

HARDY, JR ;

WILTSHAW, E ;

BLAKE, PR ;

HARPER, P ;

SLEVIN, M ;

PERREN, TJ ;

TAN, S .

ANNALS OF ONCOLOGY, 1991, 2 (02) :131-136

[18] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].

KAPLAN, EL ;

MEIER, P .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481

[19]

KAWAHARA M, 1991, CANCER, V68, P714, DOI 10.1002/1097-0142(19910815)68:4<714::AID-CNCR2820680408>3.0.CO

[20]

2-J

← 1 2 3 4 →